endometrial cancer
Conditions
Interventions
Divided into Group A and Group B according to FIGO staging:NA
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. The tumor specimens obtained from total hysterectomy or diagnostic dilation and curettage are reviewed by pathologists with at least 5 years of practice. Patients are diagnosed with endometrial cancer in accordance with the WHO Classification of Tumors of the Female Reproductive Organs (5th Edition). 2. The patient signs the informed consent form. 3. The patient has the conditions for follow-up.
Exclusion criteria
Exclusion criteria: Patients who are unable to undergo staged surgery due to the combination of severe internal and external diseases include the following cases: (1) Renal impairment; (2) Adrenal insufficiency; (3) Deep vein thrombosis or pulmonary embolism, thrombotic heart valve disease or thrombotic cardiac arrhythmia (e.g., subacute bacterial endocarditis with valve disease or atrial fibrillation); (4) Hereditary or acquired hypercoagulable states; (5) Severe cerebrovascular diseases or stroke; (6) Severe coronary heart disease or myocardial infarction; (7) Uncontrolled hypertension; (8) Severe diabetes with vascular complications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The NRI assessment indicates that the FIGO 2023 staging system demonstrates improved discriminatory ability for 5-year overall survival (OS) in FIGO stage I-II endometrial cancer (EC) patients compare; | — |
Secondary
| Measure | Time frame |
|---|---|
| The NRI assessment demonstrates that the FIGO 2023 staging system improves the classification ability for predicting 3-year and 5-year PFS as well as 3-year OS in FIGO stage III-IV EC patients compare; | — |
Countries
China
Contacts
Public ContactYang Ye
Shanghai General Hospital
Outcome results
None listed